Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Net sales	$ 184	$ 489	$ 546	$ 984
Cost of sales	(181)	(412)	(490)	(822)
Gross profit	3	77	56	162
Selling, general and administrative expenses	(38)	(50)	(82)	(102)
Research, development and engineering expenses, net	(44)	(159)	(175)	(315)
Amortization of intangibles	(1)	(6)	(3)	(11)
Other income, net	16	1	18	1
Operating loss	(64)	(137)	(186)	(265)
Loss on divestiture and assets held for sales, net	0	0	(67)	0
Loss from equity method investment	(19)	(18)	(38)	(35)
Interest income	3	4	7	8
Interest expense	(5)	(2)	(10)	(3)
Other non-operating items, net	(3)	1	(1)	1
Loss before income taxes	(88)	(152)	(295)	(294)
Income tax expense (benefit)	(2)	10	(26)	4
Net loss	(90)	(142)	(321)	(290)
Less: Net income (loss) attributable to non-controlling interest	0	(9)	1	(20)
Net loss attributable to controlling interest	$ (90)	$ (133)	$ (322)	$ (270)
Net loss per share - basic (in dollars per share)	$ (0.80)	$ (1.39)	$ (2.89)	$ (2.94)
Net loss per share - diluted (in dollars per share)	$ (0.80)	$ (1.39)	$ (2.89)	$ (2.94)
Weighted average number of shares outstanding, (in millions) (in shares)	111,580	96,060	111,520	91,680
Weighted average number of shares outstanding, assuming dilution (in millions) (in shares)	111,580	96,060	111,520	91,680